In the areas now known politically as Jordan, Syria, Lebanon and Israel/West Bank, historically known as "Greater Syria," there are approximately 3500 wild plant species, 80% of which are shared between these countries. Of these, more than 2500 species from 700 genera and some 152 plant families can be found in Jordan [1] . Although some species have been well investigated, for most plants used in traditional medicine in Jordan, thorough phytochemical studies and rigorous biological evaluations are lacking [1, 2] .
One of the more interesting medicinal plants found in Jordan are those of the genus Colchicum, as nine species have been reported in the wild, namely: C. brachyphyllum Boiss. & Haussk. ex Boiss., C. crocifolium Boiss., C. hierosolymitanum Feinbr., C. ritchii. R. Br., C. schimperi Janka, C. stevenii Kunth, C. tauri Siehe ex Stef., C. triphyllum Kunze, and C. tunicatum Feinbr [1,2-4]. The major active principle from Colchicum, colchicine, was first isolated in the early 1800s [5] , and its complete structure was determined by the 1950s [6, 7] . Although this compound has been used for the treatment of various disorders, presently (-)-colchicine, a potent antiinflammatory, is the drug of choice to relieve acute gout attack [8] .
In our continuing studies on Jordanian Colchicum species [9] [10] [11] [12] , the colchicinoids of Colchicum tauri Siehe ex Stef. (Colchicaceae) were pursued. To the best of our knowledge, this species has not been investigated previously for bioactive constituents. Colchicum tauri, characterized as a perennial herb, with underground corms covered by dark-brown, onion-like, scales, is found in South-Central Jordan near Mkawer, Madaba, flowering from December to January [1, 2, 4] . From extracts of the flowers, leaves, and corms, nine compounds, eight colchicinoids and one flavone, were isolated and characterized. One of these, (-)-3-demethyl-N-methyldemecolcine (6) is a new colchicinoid analogue, while the remaining eight known compounds are reported in this species for the first time, namely: (-)-colchicine (1), (-)-2-demethylcolchicine (2), (-)-3-demethylcolchicine (3), (-)-demecolcine (4), (-)-N-methyldemecolcine (5), β-lumicolchicine (7), 3-demethyl-β-lumicolchicine (8) , and apigenin (9) . The structures of all of the compounds were elucidated using a series of spectrometric and spectroscopic techniques. The brine shrimp lethality test (BST) was used to direct the isolation studies, and all pure compounds were evaluated for general toxicity using the BST. The dried ground plant parts: flowers, leaves, and corms of Colchicum tauri Siehe ex Stef. Colchicaceae were extracted and fractionated individually into five fractions (labeled A-E) according to the scheme of Šimánek and coworkers [13, 14] . The C-fractions from each plant part were found to be the most potent in the BST, with LC 50 values that ranged from 0.1 to 2.7 µg/mL. Thus, fraction C from each plant part was subjected to further purification using different chromatographic techniques: open columns, preparative TLC and semi-preparative HPLC. Nine pure compounds, eight known and one new, were isolated, and the structures of these were elucidated using a series of spectroscopic and spectrometric techniques, principally: 1D-NMR ( 1 H, and 13 C), 2D-NMR (COSY, ROESY, HMBC, and HSQC), mass spectra analyses (low resolution EI-MS and high resolution FAB), and by comparisons with corresponding spectral data reported in the literature. The spectral data we obtained for those known compounds were in full agreement with those reported in the literature. The identified compounds can be categorized into three classes: (-)-colchicine-type: (-)-colchicine (1) (264 mg, 0.03% w/w, plant dry weight) [11] , (-)-2-demethylcolchicine (2) (2 mg, 0.0002% w/w, plant dry weight) [15] , (-)-3-demethylcolchicine (3) (12.5 mg, 0.0013% w/w, plant dry weight) [11] , (-)-demecolcine (4) (4.7 mg, 0.0005% w/w, plant dry weight) [11] , (-)-N-methyldemecolcine (5) (61 mg. 0.007% w/w, plant dry weight) [15] , and (-)-3-demethyl-N-methyldemecolcine (6) (34 mg, 0.004% w/w, plant dry weight); lumiderivatives: β-lumicolchicine (7) (13.5 mg, 0.0014% w/w, plant dry weight) and 3-demethyl-β-lumicolchicine (8) (3.8 mg, 0.0004% w/w, plant dry weight) [11, 16] ; and flavones: apigenin (9) (5 mg, 0.0005% w/w, plant dry weight) [17] ( Figure 1 ). H-11, respectively) , and an upfield-shifted ketone carbonyl at δ C 180.3 (C-9) were characteristic for a tropolone C-ring, whose presence was confirmed by corresponding HMBC data ( Table 1 ). The methoxy signal at δ H 4.00 showed HMBC correlation with C-10, which placed this moiety at C-10. The other two methoxy groups in the molecule (δ H /δ C 3.59/60.2 and 4.02/61.4) displayed an HMBC correlation to C-1 and C-2, respectively, confirming the connection of these two methoxy's to the C-1 and C-2, respectively, as is typical in colchicinoids. The broad peak, at δ H /δ C 2.14/43.0 ppm was assigned to the N,N-dimethyl residues. This broadening can be explained by the known NMR phenomena of efficient relaxation, where the rotation around the C7-N bond is slowed down due to steric hindrance. It is known that a molecule or a segment of molecule which have a rotation times in solution near to 10 8 s -1 may have their 13 C and 1 H nuclei efficiently relaxed by dipolar relaxation, and the two singlets in NMR broaden and coalesce [18, 19] . The remaining signals verified free hydroxyl group at the C-3 position, thereby establishing the structure of 6 as (-)-3-demethyl-Nmethyldemecolcine, a new colchicine analogue. Based on the well-established biosynthetic pathway of colchicinoids, the stereochemistry at position C-7 was presumed to be S [20] [21] [22] [23] .
The identified compounds 1-9 were tested for general toxicity against the BST, in which compounds 1 and 4 were the most toxic ( Table 2) . The new compound, (-)-3-demethyl-N-methyldemecolcine (6) was not very active in this assay, and this is in keeping with similar results observed for structurally related molecules [11] .
Experimental

General Experimental
Procedures: Optical rotations, UV spectra, and IR spectra were measured with a Rudolph Autopol ® III polarimeter, a Varian Cary 3 UV-vis spectrophotometer, and a Nicolet Avatar 360 FT-IR, respectively. All NMR experiments were performed in CDCl 3 with TMS as an internal standard. The NMR spectra for compounds 1-5 and 7-9 were recorded using a Brücker AC-200 FT-NMR superconducting spectrometer, while the NMR spectra for compound 6, including gs-COSY, ROESY, gs-HSQC, gs-HMBC and 1 H NMR were acquired with a Varian Unity Inova-500 instrument using a 5 mm broadband inverse probe with z-gradient. Low-resolution EIMS were recorded at 70 eV on a VG-7070-E (Micromass, Manchester, UK). High-resolution FABMS was measured with a Micromass Autospec mass spectrometer. HPLC was performed on a Lachrom [11, 13, 14] : The collected plant raw material was cleaned and divided into three parts: flowers, leaves, and corms, with corms sliced into small pieces to speed the drying process. After drying at room temperature, all plant parts were ground to powder using a laboratory mill, and exact weights were recorded (Table 3 ). Infusions were prepared by soaking the ground plant materials (122.22 g flowers, 501.01 g leaves, and 315.92 g corms) in methanol at room temperature for one week, with frequent shaking, followed by filtration to separate plant debris, and saving the filtrate. This process was repeated eight times to ensure complete recovery, which was monitored by TLC. The collected filtrates were dried under vacuum to yield three MeOH extracts (70.64 g from flowers, 185.01 g from leaves and 115.72 g from corms). The crude alkaloid fractionation of each MeOH extract was carried out based on the method of Šimánek and coworkers [21, 22] . Fractions, A-E and methanol, were brought to dryness under vacuum and the exact weights and yield were recorded (Table 3) . 
Extraction and Isolation
Brine Shrimp Lethality Test (BST):
Fractions (A-E) and pure compounds were tested for their general cytotoxicity using Brine Shrimp Lethality Test (BST), which was performed as described previously [24, 25] .
(-)-3-demethyl-N-methyldemecolcine (6) [α] 
